7 documents found, page 1 of 1
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized wit...
Hites, M; Lapique, EL; Massonnaud, CR; Belhadi, D; Jamard, S; Goehringer, F; Danion, F; Reignier, J; de Castro, N; Garot, D; Lacombe, K; Tolsma, V
Content validation of a new measure of patient-reported barriers to antiretrovi...
Engler, K; Vicente, S; Mate, K; Lessard, D; Ahmed, S; Lacombe, K; Lebouche, BBackground Over a third of people living with HIV (PLHIV) have suboptimal adherence to antiretroviral therapy (ART). Measures of barriers to ART adherence often lack comprehensiveness. To help manage ART adherence barriers in HIV care, we are developing a new patient-reported outcome measure (PROM) of these barriers (the I-Score). Methods We assessed the content validity of 100 items (distinct barriers) to reta...
The Association Between Hepatitis B Virus Infection and Nonliver Malignancies i...
Mocroft, A; Miro, J; Wandeler, G; Llibre, J; Boyd, A; van Bremen, K; Beniowski, M; Mikhalik, J; Cavassini, M; Maltez, F; Duvivier, C; Uberti Foppa, CObjectives: The aim of this study was to assess the impact of hepatitis B virus (HBV) infection on non-liver malignancies in people living with HIV (PLWH). Methods: All persons aged ≥ 18 years with known hepatitis B virus (HBV) surface antigen (HBsAg) status after the latest of 1 January 2001 and enrolment in the EuroSIDA cohort (baseline) were included in the study; persons were categorized as HBV positive or ...
COVID-19 infection in adult patients with hematological malignancies: a Europea...
Pagano, L; Salmanton-García, J; Marchesi, F; Busca, A; Corradini, P; Hoenigl, M; Klimko, N; Koehler, P; Pagliuca, A; Passamonti, F; Verga, L; Víšek, BBackground: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-19 and analyzed predictors of mortality. Methods: The survey was supported by the Scientific Wor...
Correction to: Clinical management of ageing people living with HIV in Europe: ...
Boffito, M; Ryom, L; Spinner, C; Martinez, E; Behrens, G; Rockstroh, J; Hohenauer, J; Lacombe, K; Psichogyiou, M; Voith, N; Mallon, P; Branco, T, et al.
Clinical management of ageing people living with HIV in Europe: the view of the...
Boffito, M; Ryom, L; Spinner, C; Martinez, E; Behrens, G; Rockstroh, J; Hohenauer, J; Lacombe, K; Psichogyiou, M; Voith, N; Mallon, P; Branco, T, et al.BACKGROUND: Although guidelines for the management of HIV infection include recommendations for aging people living with HIV (PLWH), clinical practice of European HIV care providers may vary. METHOD: We performed a study using a 3-phase Delphi methodology by involving a panel of clinicians with expertise in HIV infection clinical management. The main aim of the study was to assess the care provider prospective ...
European AIDS Clinical Society Standard of Care meeting on HIV and related coin...
Mussini, C; Antinori, A; Bhagani, S; Branco, T; Brostrom, M; Dedes, N; Bereczky, T; Girardi, E; Gökengin, D; Horban, A; Lacombe, K; Lundgren, JDObjectives: The objective of the 1st European AIDS Clinical Society meeting on Standard of Care in Europe was to raise awareness of the European scenario and come to an agreement on actions that could be taken in the future. Methods: Data-driven presentations were given on specific topics followed by interactive panel discussions. Results: In Eastern European countries, the epidemic is largely driven by injecti...